69 results
424B3
GOSS
Gossamer Bio Inc
28 Aug 23
Prospectus supplement
4:29pm
and the selling securityholders take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give
S-3
GOSS
Gossamer Bio Inc
18 Aug 23
Shelf registration
8:41am
by or on behalf of us or to which we have referred you. We and the selling securityholders take no responsibility for, and can provide no assurance
S-3ASR
GOSS
Gossamer Bio Inc
17 Aug 23
Automatic shelf registration
4:01pm
by or on behalf of us or to which we have referred you. We and the selling securityholders take no responsibility for, and can provide no assurance
8-K
EX-4.1
3q0t8jn vh72o0oihw7
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
8-K
EX-10.1
w51c069opobq xph7
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
PRE 14A
2y0hukdkqa3
17 Apr 23
Preliminary proxy
4:01pm
S-3ASR
urj1asqq8rrvol272
9 Aug 22
Automatic shelf registration
12:00am
8-K
EX-10.1
btsr whlkx92ebey27t
13 Jul 22
Gossamer Bio Announces $120 million Private Placement Financing
8:45am
S-3ASR
EX-4.4
uwan2cdjettq 02la
3 Mar 22
Automatic shelf registration
4:05pm
S-3ASR
t2nnshwhs57 y8p
3 Mar 22
Automatic shelf registration
4:05pm
8-K
2sp248a3m jcm2z5lg
14 Jun 21
Gossamer Bio Announces Appointment of Sandra Milligan, M.D., J.D., to its Board of Directors
4:22pm
8-K
EX-99.1
n96z6ynzlsn29nfr3a
14 Jun 21
Gossamer Bio Announces Appointment of Sandra Milligan, M.D., J.D., to its Board of Directors
4:22pm